How much Dumirox to take
Takethe amount of Dumirox that your doctor has prescribed.
If you are unsure, consult your doctor or pharmacist..
Usual initial dose for adults (18 years and older):
Depression treatment:
•Start with 50 or 100 mg per day, taken at night.
Obsessive-compulsive disorder treatment:
• Start with 50 mg per day, preferably at night.
If you do not start to feel better after a couple of weeks, inform your doctor, who will advise you. Your doctor will tell you how to gradually increase the dose.
The maximum recommended daily dose is 300 mg.
If your doctor advises you to take more than 150 mg per day,do not takethe entire dose at once; ask your doctor when to take each dose.
Usual dose for children and adolescents with obsessive-compulsive disorder (OCD) (8 years and older):
Start with 25 mg (half a tablet) per day, preferably at bedtime. Your doctor may increase the dose every 4-7 days by 25 mg if tolerated to reach the effective dose.
The maximum daily dose is 200 mg.
If your doctor advises you to take more than 50 mg per day,do not takethe entire dose at once; ask your doctor when to take each dose. If the dose cannot be divided equally, the highest dose should be taken at night.
Children and adolescents under 18 yearsshould not takethis medication for depression. This medicationshould onlybe prescribed for children and adolescents in the case of obsessive-compulsive disorder (OCD).
How to take Dumirox
Swallow the tablets with water.Do notcrush them.
You can break the tablets in half if your doctor advises you to.
When it takes effect
Dumirox takes some time to take effect. Some patients do not feel better during the first 2 or 3 weeks of treatment.
Take thetablets until your doctor tells you to stop.
Although you feel better, your doctor may advise you to continue taking the tablets for some time, at least six months, to ensure that the medication has taken full effect.
Do not stopthe treatment with Dumirox abruptly.
You may experiencewithdrawal symptomssuch as:
- agitation and anxiety
- confusion
- diarrhea
- difficulty sleeping/intense dreams
- dizziness
- emotional instability
- headache
- irritability
- nausea and/or vomiting
- palpitations (faster heart rate)
- sensory disturbances (such as electric shock sensations or visual disturbances)
- sweating
- tremors
To withdraw from Dumirox treatment, your doctor will advise you to gradually reduce the dose over a number of weeks or months, which will help reduce the incidence of withdrawal symptoms. Most people find that withdrawal symptoms from Dumirox are mild and resolve within two weeks. For some people, these symptoms may be more severe or last longer.
If you experience withdrawal symptoms when stopping treatment, consult your doctor.Your doctor may advise you to take the tablets again and taper off more slowly (see section 4 “Possible side effects”).
If any of these symptoms occur when withdrawing from treatment,consult your doctor.
If you take too much Dumirox
If you or someone has taken more Dumirox than they should (an overdose), inform your doctor, go directly to the hospital, or call the Toxicology Information Service, phone 91 562 04 20,indicating the medication and the amount taken. Bring the medication packaging with you.
The symptoms of an overdose include, but are not limited to, nausea, vomiting, diarrhea, and a feeling of drowsiness or dizziness. Cardiac symptoms (slow or fast heart rate, low blood pressure) have been reported, as well as liver complications, seizures (attacks), and coma.
If you forget to take Dumirox
If you forget to take a tablet, wait until the next dose. Do not take a double dose to make up for the missed doses.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, Dumirox may cause side effects, although not everyone experiences them.The frequencies of side effects observed are defined as described below:
Very common | affects more than 1 in 10 patients |
Common | affects between 1 and 10 in 100 patients |
Uncommon | affects between 1 and 10 in 1,000 patients |
Rare | affects between 1 and 10 in 10,000 patients |
Very rare | affects less than 1 in 10,000 patients |
Unknown | cannot be estimated from available data |
Side effects related to this type of medication
In some cases, you may experience or have an increase insuicidal thoughts or self-harmduring the first weeks of treatment with Dumirox, until the antidepressant effect occurs.
Inform your doctor immediatelyif you have anxious thoughts or experiences.
Ifyou have several symptoms at the same timeyou may have one of the rare conditions described below:
• Serotonin syndrome: If you have sweating, muscle rigidity or spasms, instability, confusion, irritability, or extreme agitation.
• Neuroleptic malignant syndrome: If you have muscle rigidity, fever, confusion, and other related symptoms.
• SIADH: If you feel tired, weak, or confused, and have muscle pain, numbness, or uncontrolled movements.
• Severe skin reactions, such as skin eruptions or severe redness, including generalized rash, which starts on the extremities on both sides of the body and evolves into concentric circles resembling erythema (erythema multiforme), generalized skin rash with blisters and skin peeling, which occurs especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome), extensive skin peeling (more than 30% of the body surface - toxic epidermal necrolysis). The frequency of these side effects is unknown (cannot be estimated from available data).
Stop taking Dumiroxand consult your doctor immediately.
If you experience unusual bruises or purple rashes on your skin or if you vomit blood or have blood in your stool, contact your doctor.
Stopping fluvoxamine (especially when done abruptly) often leads to withdrawal symptoms (see section 3 withdrawal symptoms).
Sometimes patientsexperience nauseawhen starting treatment with Dumirox, as it begins to take effect. Although the sensation of nausea is unpleasant, it should pass over time if you continue taking the tablets as prescribed. This may occur a few weeks after starting treatment.
Side effects caused by Dumirox
Common side effects:
- agitation
- anxiety
- constipation
- diarrhea
- difficulty sleeping
- dizziness
- dry mouth
- faster heart rate
- drowsiness (lethargy)
- discomfort
- headache
- indigestion
- loss of appetite
- nervousness
- stomach pain
- sweating
- tremor
- muscle weakness (asthenia)
- vomiting
Uncommon side effects:
- allergic skin reactions (including facial sweating, lip or tongue swelling, rash, or itching)
- confusion
- delayed ejaculation
- dizziness when standing up too quickly
- hallucinations
- lack of coordination
- muscle or joint pain
- aggression
Rare side effects:
- seizures
- liver disorders
- mania (feeling of hyperexcitement)
- photosensitivity
- unexpected milk flow
Very rare side effects:
- akathisia (agitation)
- abnormal taste
- anorgasmia (not reaching orgasm)
- in women: menstrual irregularities (monthly bleeding)
- excessive vaginal bleeding after childbirth (postpartum hemorrhage), see "Pregnancy" in section 2 for more information
- urinary disorders (such as frequent urination during the day and/or night, sudden loss of bladder control during the day and/or night, or inability to urinate)
- paresthesia (tingling or numbness)
- increased prolactin (a hormone that stimulates milk production in breastfeeding mothers)
- dilated pupils
- changes in body weight
- glaucoma (increased eye pressure).
A higher risk of bone fractures has been observed in patients taking this type of medication.
Unknown frequency
- excessive vaginal bleeding after childbirth (postpartum hemorrhage), see "Pregnancy" in section 2 for more information.
Side effects related to OCD treatment in children and adolescents, frequencies are not provided
- hypomania (feeling of euphoria and overexcitement)
- agitation
- seizures
- difficulty sleeping (insomnia)
- fatigue (asthenia)
- hyperactivity (hyperkinesia)
- feeling of drowsiness
- indigestion
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication
Keep out of reach and sight of children.
- Do not use the tablets after the expiration date that appears on the box after “CAD” or “EXP”. The expiration date is the last day of the month indicated.
- Do not store at a temperature above 25 °C.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medicines you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Dumirox
The active ingredient is fluvoxamine maleate.
Each tablet contains 100 mg of fluvoxamine as maleate.
The other components are mannitol (E421), cornstarch without gluten, pregelatinized starch, sodium stearoylfumarate, anhydrous colloidal silica, hypromellose, macrogol 6000, talc, and titanium dioxide (E171).
Appearance of the product and contents of the package
Dumirox 100 mg is presented in the form of coated tablets, white or almost white, oval, and with a mark “313” on the two sides separated by the dividing line.
Dumirox 100 mg is available in packages of 15, 20, 30, 50, 60, 90, 100, 120, and 250 tablets.
Only some package sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder
Mylan IRE Healthcare Limited
Unit 35/36 Grange Parade,
Baldoyle Industrial Estate, Dublin 13
Ireland
Responsible for manufacturing
Mylan Laboratories SAS
Route de Belleville Lieu dit Maillard
01400 Châtillon-sur-Chalaronne
France
Recipharm Parets, S.L.U.
C/ Ramón y Cajal 2
08150 Parets del Vallés (Barcelona)
Spain
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Mylan Pharmaceuticals, S.L.
C/ Plom, 2-4, 5th floor
08038 - Barcelona
Spain
This pharmaceutical product is authorized in the member states of the EEA under the following names:
Austria Floxyfral
Belgium Floxyfral
Denmark Fevarin
Finland Fevarin
France Floxyfral
Germany Fevarin
Greece Dumyrox
Ireland Faverin
Italy Dumirox
Luxembourg Floxyfral
Norway Fevarin
Portugal Dumyrox
Spain Dumirox
Sweden Fevarin
Netherlands Fevarin
United Kingdom Faverin
Last reviewed date of this leaflet: April 2025
More detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.